Hepatic Hemangiomas on Ultrasound: How Primary Care Providers Should Interpret This Incidental Liver Lesion
Abdominal ultrasounds are frequently ordered in primary care for a variety of indications. One common and often unexpected incidental finding is a hepatic hemangioma, also referred to as a cavernous hemangioma.
Many clinicians encounter this finding in a radiology report and wonder: Does this require further investigation?
This article reviews the key clinical features, imaging findings, and management approach to hepatic hemangiomas in primary care.
🔍Case: You order an abdominal ultrasound for a 40-year-old male patient to rule out biliary colic.
The radiology report shows a normal gallbladder and common bile duct with no gallstones or sludge. However, an incidental liver lesion is noted.
The report states: Lesion 1: Segment III hyperechoic lesion with no internal flow, measuring 0.9 × 0.5 × 0.5 cm. Probable hepatic hemangioma, particularly in a low-risk patient without risk factors for hepatocellular carcinoma or a history of malignancy.
You now ask yourself: How should this finding be interpreted, and when does it require further imaging?
What Is a Hepatic Hemangioma?
A hepatic hemangioma is a benign vascular tumour of the liver composed of clusters of blood-filled vascular cavities supplied by the hepatic artery.
Most hepatic hemangiomas are asymptomatic and are discovered incidentally during imaging performed for unrelated reasons.
Prevalence of Hepatic Hemangiomas
Hepatic hemangiomas are the most common benign liver lesion.
Key epidemiologic features include:
Usually solitary, although multiple lesions can occur
Can occur at any age
Most commonly diagnosed between ages 30–50
Occur more frequently in females
Exposure to estrogen (pregnancy or medications) may increase lesion size (1)
Clinical Features of Hepatic Hemangiomas
Because these lesions are usually discovered incidentally on abdominal imaging, most patients are asymptomatic.
Symptoms are uncommon and typically occur only when lesions are very large (for example >10 cm).
Unless exposed to estrogen, hemangiomas typically do not increase in size over time and rarely cause complications (2).
When symptoms occur, they may include:
Right upper quadrant abdominal pain
Reduced appetite
Early satiety
Nausea or vomiting
Postprandial bloating (2)
Physical Exam and Laboratory Findings for Hepatic Hemangioma
The physical exam is typically normal. In rare cases of very large lesions, a palpable liver mass may be detected (1).
Abnormal liver biochemical tests are uncommon (1).
💡 Clinical Tip: Mild elevations in routine liver enzymes such as ALT or AST do not independently increase the risk of malignancy in the absence of other liver disease or risk factors (3).
Typical Ultrasound Features of a Hepatic Hemangioma
Ultrasound is often the first imaging modality that identifies hepatic hemangiomas.
Typical features include:
Size <3 cm
Homogeneously hyperechoic appearance, or iso/hypoechoic lesion with a hyperechoic rim
Well-defined margins
No internal Doppler flow
No posterior acoustic shadowing
When these classic imaging features are present in a low-risk patient, the diagnosis is usually straightforward and no further imaging is required (1, 3). If the patient has a large hemangioma (e.g. >10cm) and is symptomatic, referral to a specialist is recommended.
💡For weekly diagnostic imaging insights and practice-changing pearls, join NP Reasoning Masterclass.
Approach to an Incidental Hepatic Hemangioma
When a possible hemangioma is identified, the key clinical question is: Is the patient low risk or high risk for hepatocellular carcinoma (HCC)?
The answer to this question determines whether further imaging is needed.
High-Risk Patients for Hepatocellular Carcinoma
Patients are considered higher risk if they have:
1) History of malignancy
Particularly cancers that commonly metastasize to the liver, including:
Colorectal cancer
Pancreatic cancer
2) Underlying liver disease (e.g. chronic viral hepatitis, NASH, MAFLD, cirrhosis)
3) Other risk factors for hepatocellular carcinoma, including:
Alcohol use disorder
Primary sclerosing cholangitis
Primary biliary cholangitis
Choledochal cysts
Hemochromatosis
Anabolic steroid use
Certain hereditary liver diseases
Elevated tumour markers (3)
Use of oral contraceptives or exogenous estrogen may also warrant further evaluation because these medications increase the risk of hepatic adenomas, which may appear similar on imaging.
Low-Risk Patients for HCC
Low-risk patients typically have:
No history of malignancy
No underlying liver disease
No hepatocellular carcinoma risk factors
When classic hemangioma features are present on ultrasound in a low-risk patient, no further imaging or follow-up is required, as the lesion is highly likely to represent a benign hemangioma (3).
💡Bottom line: in a low-risk patient with classic hepatic hemangioma imaging findings, no further work-up is necessary. If the patient has a large hemangioma (e.g. >10cm) and is symptomatic, referral to a specialist is recommended.
When Should You Order Additional Imaging for a Hepatic Hemangioma?
If the patient is high risk, additional imaging is recommended to confirm the diagnosis.
Preferred imaging modalities include:
Contrast-enhanced CT abdomen
MRI liver
These studies help differentiate hemangiomas from other hepatic lesions, including malignancy.
Typical CT Findings of a Hepatic Hemangioma
Most hemangiomas are well-defined lesions. Their enhancement pattern reflects their vascular architecture.
Typical CT features include:
Non-contrast phase: Homogeneous hypoattenuation relative to liver parenchyma
Late arterial phase
Discontinuous nodular peripheral enhancement
Small lesions may enhance more uniformly
Portal venous phase: Progressive peripheral enhancement with centripetal fill-in
Delayed phase: continued irregular fill-in, becoming iso- or hyperattenuating relative to liver parenchyma (4)
Typical MRI Findings of a Hepatic Hemangioma
MRI provides highly characteristic imaging features.
Typical findings include:
T1: Hypointense relative to liver parenchyma
T2: Hyperintense relative to liver parenchyma, less intense than cerebrospinal fluid or a hepatic cyst
Contrast-enhanced T1 (gadolinium): Peripheral nodular discontinuous enhancement with centripetal filling on delayed images (4)
Primary Care Pearl: Radiologists may recommend additional imaging in the ultrasound report if a lesion appears atypical or if the diagnosis is uncertain. Plus, radiologists may not be aware of a patient’s individual clinical risk factors, which are essential for determining the need for further evaluation.
🔍Back to the case: in reviewing your patient’s chart and following up with him, you realize he does not have any history of cancer, and has no additional risk factors for HCC. You can be reassured that no further diagnostic imaging is indicated at this time.
Helpful Imaging Algorithms for Liver Masses
The Canadian Association of Radiologists guideline on incidental liver findings provides practical algorithms for evaluating focal hepatic lesions detected on ultrasound or CT. See pages 439–440 of the guideline for detailed diagnostic pathways.
ReferencesCurry MP, Chopra S. Hepatic hemangioma. In: Lindor KD, editor. UpToDate. Waltham (MA): UpToDate Inc.; 2026. Available from: https://www.uptodate.com/contents/hepatic-hemangiomaBajenaru N, Balaban V, Săvulescu F, Campeanu I, Patrascu T. Hepatic hemangioma: review. J Med Life. 2015;8(Spec Issue):4-11. PMID: 26361504; PMCID: PMC4564031.Bird JR, Brahm GL, Fung C, Sebastian S, Kirkpatrick IDC. Recommendations for the management of incidental hepatobiliary findings in adults: endorsement and adaptation of the 2017 and 2013 ACR Incidental Findings Committee white papers by the Canadian Association of Radiologists Incidental Findings Working Group. Can Assoc Radiol J. 2020;71(4):437-47. doi:10.1177/0846537120928349. Available from: https://x-ray.ca/wp-content/uploads/2026/02/Liver-Incidental-Findings-CAR-Guideline.pdfWeerakkody Y, Rasuli B, Le L, et al. Hepatic hemangioma. Radiopaedia.org. Available from: https://doi.org/10.53347/rID-7565. Accessed 2026 Mar 17.

